Hospital
Naples Hma LLC
Naples Hma LLC was paid $2.95M by Medicaid between Jan 2018 and Nov 2024, across 97 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoNAPLES HMA LLC
NAPLES, FL 34114
NAPLES, FL 34114
33aNPI1215003348assigned 11/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.95M
24GClaims131,680
24DCodes billed97
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#107 of 163
Median peer was paid$4.77M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,531 | $73K | |
| 2019 | 21,746 | $358K | |
| 2020 | 21,095 | $261K | |
| 2021 | 34,783 | $758K | |
| 2022 | 35,904 | $1.01M | |
| 2023 | 11,195 | $357K | |
| 2024incomplete | 1,426 | $139K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 8,696 | 7,864 | $568K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 6,430 | 5,600 | $412K |
| 41899 | Unlisted procedure, dentoalveolar structures | 13% | 925 | 899 | $382K |
| 36415 | Collection of venous blood by venipuncture | 11% | 9,049 | 6,403 | $334K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.6% | 1,027 | 939 | $194K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.7% | 1,003 | 892 | $168K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.8% | 2,936 | 2,389 | $142K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.5% | 2,573 | 2,138 | $134K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.4% | 1,475 | 1,244 | $130K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 1,552 | 1,401 | $94K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.6% | 2,425 | 2,173 | $78K |
| G0378 | Hospital observation service, per hour | 2.3% | 439 | 377 | $69K |
85 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 566 | $24K |
| 87400 | <1% | 770 | $20K | |
| 88300 | <1% | 577 | $16K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,039 | $16K |
| 81025 | <1% | 2,978 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,255 | $11K |
| 87428 | <1% | 1,827 | $11K | |
| 99218 | <1% | 56 | $11K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,088 | $10K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,320 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,399 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,975 | $8K |
| 84484 | <1% | 3,199 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,373 | $6K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 121 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 552 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,453 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 302 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,426 | $4K |
| 81001 | <1% | 3,690 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,200 | $3K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,866 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,958 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 317 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,139 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 45 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,557 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 263 | $2K |
| 72131 | <1% | 15 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 477 | $2K |
| 82962 | <1% | 1,345 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,586 | $2K |
| 81003 | <1% | 1,229 | $1K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 456 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,311 | $1K |
| 94760 | <1% | 1,548 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,963 | $1K |
| 87430 | <1% | 365 | $1K | |
| 85610 | <1% | 2,253 | $1K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 48 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 178 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 831 | $1K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 149 | $960.67 |
| 83690 | <1% | 2,799 | $939.28 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 29 | $906.46 |
| 82550 | <1% | 525 | $897.20 | |
| 83735 | <1% | 2,570 | $883.76 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,232 | $810.11 |
| 87186 | <1% | 354 | $779.57 | |
| 87077 | <1% | 369 | $778.69 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 725 | $766.93 |
| 83880 | <1% | 729 | $761.28 | |
| 86901 | <1% | 55 | $757.32 | |
| 85027 | <1% | 796 | $701.98 | |
| 85730 | <1% | 1,746 | $530.85 | |
| 96376 | <1% | 134 | $477.35 | |
| 83605 | <1% | 417 | $284.97 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,629 | $266.97 |
| 94664 | <1% | 59 | $251.99 | |
| 87040 | <1% | 305 | $216.15 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 968 | $216.00 |
| 73630 | <1% | 31 | $114.99 | |
| 73562 | <1% | 17 | $109.91 | |
| 80061 | Lipid panel | <1% | 352 | $84.70 |
| 87807 | <1% | 43 | $81.95 | |
| 85379 | <1% | 312 | $75.04 | |
| 86140 | <1% | 167 | $59.61 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 26 | $27.96 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 130 | $19.86 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 161 | $16.67 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 161 | $8.34 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 16 | $0.00 |
| 82077 | 0% | 106 | $0.00 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 0% | 15 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 103 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 12 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 25 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 12 | $0.00 |
| 84702 | 0% | 226 | $0.00 | |
| 86900 | 0% | 55 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 430 | $0.00 |
| G1002 | Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program | 0% | 181 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 39 | $0.00 |
| 82248 | 0% | 12 | $0.00 | |
| 73610 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.